Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Klopfenstein et al
- PMID: 34162596
- DOI: 10.1136/annrheumdis-2021-220787
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Klopfenstein et al
Keywords: COVID-19; biological therapy; epidemiology.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.Ann Rheum Dis. 2020 Sep;79(9):1143-1151. doi: 10.1136/annrheumdis-2020-218479. Epub 2020 Jul 20. Ann Rheum Dis. 2020. PMID: 32719045 Free PMC article. Clinical Trial.
-
Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.Ann Rheum Dis. 2023 Jul;82(7):e153. doi: 10.1136/annrheumdis-2021-220771. Epub 2021 Jun 23. Ann Rheum Dis. 2023. PMID: 34162593 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
